Therapy Areas: Infectious Diseases
Quest Diagnostics to dispose Indian diagnostics business
8 October 2018 -

Diagnostic information services company Quest Diagnostics (NYSE:DGX) disclosed on Friday the launch of an agreement to divest its India medical diagnostics business to Strand Life Sciences, a specialised diagnostics company based Bangalore, India, for an undisclosed amount.

According to Dr Ramesh Hariharan, CEO of Strand Life, the acquisition is an important addition to its network of 24 diagnostic labs across India as it continues to expand in oncology, genomics and precision medicine. The acquisition adds three reference labs, 45 touch points and leading corporate and pharmaceutical clients to its portfolio.

In conjunction, the two companies will work together to manage the transition and aim to close the sale by the end of first quarter 2019.

Strand Life Sciences is a clinical research and diagnostics company that combines bioinformatics with cutting-edge laboratory assays and a vast hospital partner network to drive newer generations of patient care. Strand's customers include global instrument, diagnostic and pharmaceutical companies. Its diagnostics menu makes it India's leading integrated specialised diagnostics company, covering oncology, genetics, fertility, women's health, infectious diseases and general wellness.



Related Headlines